SS
Sanjana Sanjeev Shah
About Sanjana Sanjeev Shah
Data last updated:
Sanjana Sanjeev Shah is a Director at Remus Pharmaceuticals Limited (since 2023) and Cfo at Sancode Technologies Limited (since 2023). The companies operate in Trading and Information Technology. The 2 current companies with reported revenue have a combined latest revenue of ₹640 Cr; the largest is Remus Pharmaceuticals Limited at ₹625 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Remus Pharmaceuticals Limited L24232GJ2015PLC084536 | Director | 06 Jan 2023 | 2015 | ₹625 Cr (FY 2025) | Active |
 Sancode Technologies Limited L74900MH2016PLC280315 | Cfo | 04 Mar 2023 | 2016 | ₹14.24 Cr (FY 2025) | Active |
Board colleagues of Sanjana Sanjeev Shah
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sanjana Sanjeev Shah
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sanjana Sanjeev Shah
Sanjana Sanjeev Shah currently holds 2 directorships: Remus Pharmaceuticals Limited (Director, since 06 Jan 2023, revenue ₹625 Cr (FY 2025)); Sancode Technologies Limited (Cfo, since 04 Mar 2023, revenue ₹14.24 Cr (FY 2025)).
Sanjana Sanjeev Shah was first appointed on 06 Jan 2023 as Director at Remus Pharmaceuticals Limited.
The 2 current companies of Sanjana Sanjeev Shah that report revenue have a combined latest revenue of ₹640 Cr: Remus Pharmaceuticals Limited ₹625 Cr (FY 2025); Sancode Technologies Limited ₹14.24 Cr (FY 2025).
The current boards of Sanjana Sanjeev Shah's companies include Anar Swapnil Shah (Remus Pharmaceuticals Limited), Arpit Deepakkumar Shah (Remus Pharmaceuticals Limited), Ashutosh Naginbhai Valani (Remus Pharmaceuticals Limited), Balwant Purohit (Remus Pharmaceuticals Limited), Bhavik Rashmikant Shah (Remus Pharmaceuticals Limited), Deval Bakulkumar Patel (Remus Pharmaceuticals Limited), among others.